We use analytics to improve Pollar and, with your consent, the Meta pixel to measure sign-ups and purchases that come from our ads. You can change this anytime in Settings. Privacy policy

Search⌘K
HomeFor YouLiveBriefAsk
MapMarketsThreadsSoundsFilmsRadar
DomesticGeopoliticsEconomySocietyScience & TechInfrastructureSportCultureLifestyle
Support Pollar
ContactPublisher
Mike Doustdar

Mike Doustdar

CEO of Novo Nordisk
Watch in RadarView on Wikipedia

Photo: Canyak1982, CC0 (Wikimedia Commons, cropped)

Headlines and summaries are written by AI. How it works

  • Sep 21

    Novo Nordisk targets five blockbusters by 2030 as shares drop up to 9% in London

    At its Capital Markets Day in London, Novo Nordisk outlined targets to launch over five blockbuster drugs by 2030 and generate 150 billion Danish crowns in pipeline sales by 2035, as shares dropped up to 9% following investor questions over pricing.

  • About
  • Editorial standards
  • Corrections
  • AI policy
  • Privacy
  • Terms
  • Contact

Top stories now

  • 16:00Bomb threats disrupt flights across Europe, six in Italy
  • 15:22Russell Brand convicted of rape, sentencing set for Monday
  • 14:24Hubert Aiwanger dead at 55, Freie Wähler face leadership gap

Morning Brief 05:05

Democrats seize Congress after Iran war
Synthetic voice (AI)
Read the Brief
HomeBriefLiveThreadsSearch